Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan
- Status
- TERMINATED
- Phase
- PHASE1
A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of ABT-869 in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Solid Tumors Using Ixabepilone and Dasatinib
- Status
- COMPLETED
- Phase
- PHASE1
AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of CALAA-01 to Treat Solid Tumor Cancers
- Status
- TERMINATED
- Phase
- PHASE1
An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1